| Summary: | We have developed a new idea to synthesize a key intermediate molecule by utilizing deep eutectic solvent (DES) and ultrasound in a multistep reaction to ensure process cost-effectiveness. To confirm the stability of reagents with DES, electronic energies were calculated at the B3LYP/6-31+G(d,p) level of theory. DES stabilized the reagents mainly due to strong intermolecular hydrogen bonding. Key intermediate (3) and final compounds (<b>4a</b>−<b>n</b>) were synthesized in a higher yield of 95% and 80%−88%, respectively. Further, final compounds (<b>4a</b>−<b>n</b>) were assessed for their anti-inflammatory, analgesic, ulcerogenic, and lipid peroxidation. The compounds <b>4f</b>, <b>4g</b>, <b>4j</b>, <b>4l</b>, and <b>4m</b> showed good anti-inflammatory activity, while <b>4f</b>, <b>4i</b>, and <b>4n</b> exhibited very good analgesic activity as compared to the standard drug. The ulcerogenicity of selected compounds was far less than the indomethacin. The ligands had also shown a good docking score (<b>4f</b> = −6.859 kcal/mol and <b>4n</b> = −7.077 kcal/mol) as compared to control indomethacin (−6.109 kcal/mol) against the target protein COX-2. These derivatives have the potential to block this enzyme and can be used as NSAID. The state-of-art DFT theory was used to validate the lipid peroxidation mechanism of the active compounds which was in good agreement with the variations of BDEs and IP of the tested compounds.
|
|---|
